57044 Federal Register / Vol. 75, No. 180 / Friday, September 17, 2010 / Notices 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; EUREKA. 

Date: November 8, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Amalfi Hotel, 200 West Kinzie 

Street, Chicago, IL 60654. 

Contact Person: William C. Benzing, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, DHHS/NIH/NINDS/DER/ 

SRB, Neuroscience Center, 6001 Executive 

Blvd., Suite 3204, MSC 9529, Bethesda, MD 

20892, 301–496–0660, 

Benzingw@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: September 10, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23268 Filed 9–16–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel 

Fellowships and Dissertations. 

Date: October 13, 2010. 

Time: 11 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Enid Light, PhD, Scientific 

Review Officer, Division of Extramural 

Activities, National Institute of Mental 

Health, NIH, Neuroscience Center, 6001 

Executive Boulevard, Room 6132, MSC 9608, 

Bethesda, MD 20852, 301–443–3599, 

elight@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel 

Developing & Advance Centers for 

Intervention and Services Research. 

Date: October 22, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Francois Boller, MD, PhD, 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6142, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–1513, 

bollerf@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: September 10, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23265 Filed 9–16–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC)—Ethics 

Subcommittee (ES) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the CDC announces 

the following meeting of the 

aforementioned subcommittee: 

Times and Dates: 1 p.m.–5 p.m., October 

7, 2010; 8:30 a.m.–12:30 p.m., October 8, 

2010. 

Place: CDC, Thomas R. Harkin Global 

Communications Center, Distance Learning 

Auditorium, 1600 Clifton Road, NE., Atlanta, 

GA 30333. This meeting is also available by 

teleconference. Please dial (877) 928–1204 

and enter code 4305992. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 60 people. To 

accommodate public participation in the 

meeting, a conference telephone line will be 

available. The public is welcome to 

participate during the public comment. The 

public comment periods are tentatively 

scheduled for 4 p.m.–4:15 p.m. on October 7, 

2010 and from 12 p.m.–12:15 p.m. on 

October 8, 2010. 

Purpose: The ES will provide counsel to 

the ACD, CDC, regarding a broad range of 

public health ethics questions and issues 

arising from programs, scientists and 

practitioners. 

Matter To Be Discussed: Agenda items will 

include the following topics: Plans for 

obtaining public comment on the ventilator 

guidance document; efforts to support state, 

tribal, local and territorial health 

departments address ethical issues in the 

practice of public health; and ethical issues 

relating to patient notification following 

infection control lapses. 

The agenda is subject to change as 

priorities dictate. 

Contact Person for More Information: For 

security reasons, members of the public 

interested in attending the meeting should 

contact Drue Barrett, PhD, Designated 

Federal Official, ACD, CDC–ES, 1600 Clifton 

Road, NE., M/S D–50, Atlanta, Georgia 

30333. Telephone (404) 639–4690. E-mail: 

dbarrett@cdc.gov. The deadline for 

notification of attendance is October 1, 2010. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 10, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–23228 Filed 9–16–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

NIOSH List of Antineoplastic and Other 

Hazardous Drugs in Healthcare 

Settings 2010 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of Final Document. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) 

announces the publication of the 

following document entitled ‘‘NIOSH 

List of Antineoplastic and Other 

Hazardous Drugs in Healthcare Settings 

2010.’’ The document can be found at 


wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1